Drug Trial Radar · NCT07836504
A Pharmacokinetic Study of HS-10504 in Participants With Hepatic Impairment and Normal Hepatic Function.
Last checked: Nov 19, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
32
Planned (sponsor's estimate)
Start
Sep 30, 2026
Primary completion
Sep 25, 2027
Study completion Oct 30, 2027
Sponsor
- Lead sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a two-part single-center, open-label, parallel, single-dose pharmacokinetic study of HS-10504 in participants with hepatic impairment and normal hepatic function.
Conditions
- To Compare the Pharmacokinetic (PK) Differences of HS-10504 Between Participants With Hepatic Impairment and Participants With Normal Hepatic Function
Interventions
HS-10504Drug
HS-10504:On Day 1, a single oral dose of 400 mg HS-10504 tablet was administered in the fasting state.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of PK parameters of HS-10504: CmaxTime frame: 216 hours after administration of HS-10504
- Evaluation of PK parameters of HS-10504: AUC0-tTime frame: 216 hours after administration of HS-10504
- Evaluation of PK parameters of HS-10504: AUC0-∞Time frame: 216 hours after administration of HS-10504
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.